Voyager Therapeutics (VYGR) Prepaid Assets (2014 - 2026)
Voyager Therapeutics (VYGR) posted Prepaid Assets of $3.9 million for Q1 2026, down 10.88% sequentially from $4.3 million in Q4 2025, and down 45.5% YoY from $7.1 million in Q1 2025.
Voyager Therapeutics (VYGR) Prepaid Assets (2014 - 2026) Analysis & Trends
Voyager Therapeutics has reported Prepaid Assets for 13 years, with the latest figure at $3.9 million in Q1 2026.
- Quarterly Prepaid Assets fell 45.5% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (down 45.5% YoY) and the FY2025 annual result came in at $4.3 million, down 45.53% from the prior year.
- Prepaid Assets fell to $3.9 million in Q1 2026 per VYGR's latest filing, from $4.3 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $9.8 million in Q2 2025 and troughed at $3.4 million in Q2 2022.
- A 5-year average of $5.9 million and a median of $5.7 million in 2023 frame the typical range for Prepaid Assets.
- The widest YoY moves for Prepaid Assets: up 296.62% in 2022, down 64.16% in 2022.
- Over 5 years, Prepaid Assets stood at $5.4 million in 2022, then retreated by 1.41% to $5.3 million in 2023, then surged by 49.4% to $7.9 million in 2024, then tumbled by 45.53% to $4.3 million in 2025, then fell by 10.88% to $3.9 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $3.9 million, $4.3 million, and $6.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Voyager Therapeutics | 205.86 Mn | 89.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.74 Mn |
| Mar 31, 2026 | 3.86 Mn |
| Dec 31, 2025 | 4.33 Mn |
| Sep 30, 2025 | 6.62 Mn |
| Jun 30, 2025 | 9.77 Mn |
| Mar 31, 2025 | 7.08 Mn |
| Dec 31, 2024 | 7.95 Mn |
| Sep 30, 2024 | 8.42 Mn |
| Jun 30, 2024 | 7.30 Mn |
| Mar 31, 2024 | 6.11 Mn |
| Dec 31, 2023 | 5.32 Mn |
| Sep 30, 2023 | 5.74 Mn |
| Jun 30, 2023 | 6.08 Mn |
| Mar 31, 2023 | 3.98 Mn |
| Dec 31, 2022 | 5.39 Mn |
| Sep 30, 2022 | 5.08 Mn |
| Jun 30, 2022 | 3.42 Mn |
| Mar 31, 2022 | 3.61 Mn |
| Dec 31, 2021 | 1.36 Mn |
| Sep 30, 2021 | 3.54 Mn |